George Simeon

Director, 10% Owner · ADARx Pharmaceuticals, Inc.

Every open-market stock purchase George Simeon has reported to the SEC on Form 4 that met our signal bar, parsed straight from the filings. This page tracks where those buys landed inside insider clusters and how the prices paid compare to where the stock trades now.

Total bought
$78.7M
Open-market buys
6
Companies
2
Last buy
Sep 28, 2026

Where the buys stand today

  • CRSP
    CRISPR Therapeutics AG
    +19.0% vs price paid

    3 purchases totalling $51.5M at an average of $52.03 per share; the stock last traded at $61.89. See all insider buying in CRSP →

    Avg price paid
    $52.03
    Latest price
    $61.89
    Market cap
    $6.0B
  • ADRX
    ADARx Pharmaceuticals, Inc.

    3 purchases totalling $27.2M at an average of $17.00 per share. See all insider buying in ADRX →

    Avg price paid
    $17.00
    Latest price
    —
    Market cap
    Unknown

Cluster participation

Qualifying buys grouped with other insiders buying the same stock — the pattern this site exists to catch.

All reported buys

DateTickerSharesPriceValueFiling
Sep 28, 2026
ADRXcluster
592,593$17.00$10.1MSEC ↗
Sep 28, 2026
ADRXcluster
414,814$17.00$7.1MSEC ↗
Sep 28, 2026
ADRXcluster
592,593$17.00$10.1MSEC ↗
Jul 16, 2025
CRSPcluster
22,319$52.03$1.2MSEC ↗
Jul 16, 2025
CRSPcluster
960,983$52.03$50.0MSEC ↗
Jul 16, 2025
CRSPcluster
6,510$52.03$338.7KSEC ↗

Follow new qualifying clusters involving George Simeon or other insiders

Explore qualifying clusters from public SEC filings. Pro adds email and Telegram notifications after detection.

About this data

Figures are parsed from George Simeon's Form 4 filings on SEC EDGAR (CIK 1595117) and cover open-market purchases (transaction code P) — grants, option exercises, and sales are excluded, which is why totals here can differ from raw filing counts. Every row links to its source document.

This page is informational and reflects public filing data. It is not investment advice.